Anesthesia; Adverse Effect, Congenital Heart Disease, Neurodevelopmental Disorders
Conditions
Brief summary
The purpose of this study is to assess whether the type of anesthesia, narcotic-based versus inhalational anesthesia administered during cardiopulmonary bypass (CPB) surgery contributes to the wide variation in neurologic recovery and developmental outcome after surgery in infants with congenital heart disease.
Detailed description
All subjects will be consented prior to participation in this study and prior to randomization. All the subjects enrolled in the study will receive a preoperative assessment by one of the cardiac anesthesiologists and receive standardized induction with sevoflurane up to 2%, 2 mcg/kg of fentanyl and 1 mg/kg of rocuronium. The anesthetic maintenance will be determined using a computer- generated randomization table and assigning each patient to one of the two anesthetic regimens. Both of these anesthetic techniques are standard of care and are commonly used for these procedures. Anesthetic Technique: Volatile anesthetic: In volatile anesthetic technique, maintenance of anesthesia will be standardized to the volatile anesthetic isoflurane. Isoflurane will be used for the study since this is what is presently available on the CPB machines. Anesthesia at 1.0 minimum anesthetic concentration (MAC) indicates that at this concentration 50% of the patients will not move when surgically stimulated. Anesthesiologists commonly use about 1.2-1.4 MAC in neonates, since the MAC value in infants is higher than that of children and adults. Isoflurane will be delivered at 1.5-2.0%% as required for anesthetic management. Rocuronium or pancuronium will be used for muscle relaxation. Narcotic, fentanyl will be administered at no greater than 2 mcg/kg/hr. Narcotic-based anesthetic: In narcotic based anesthetic technique, no volatile anesthetics will be used except during induction. Maintenance of anesthesia will be with fentanyl 5 mcg/kg/hr not to exceed 10 mcg/kg/hr. The anesthetic may be supplemented with dexmedetomidine 0.05 mcg/kg/hr but not to exceed 1.0 mcg/kg/hr. Narcotic-based anesthetic will be used by the cardiac anesthesia team and the CPB technician throughout the operative case. 5 mcg/kg/hr of fentanyl is felt to represent 0.6 MAC of anesthesia. Postoperative Sedative and Analgesic Care: As per institutional standard of care, postoperative sedation will consist of fentanyl infusions of 2-4 mcg/kg/hr for the first 48 hours postoperatively. A total of 9 Blood samples will be collected at different time points throughout the entire study for metabolomics determination (NAA/Cr and Chol/Cr) EEG monitoring will be done for baseline in the pre-operative period for 15-20 minutes, during surgery and post-operatively up to 48 hours and prior to discharge for 15-20 minutes. Neurological and behavioral testing including Bayley Exam III will be done at 18-48 months.
Interventions
Isoflurane (volatile anesthesia) will be delivered at 1.5-2.0%% as required for anesthetic management.
Fentanyl (narcotic anesthesia) maintenance will be with fentanyl 5 mcg/kg/hr not to exceed 10 mcg/kg/hr.
Fentanyl (narcotic anesthesia) maintenance will be with fentanyl 2 mcg/kg/hr.
Sponsors
Study design
Masking description
EEG, metabolic/NMRS analysis and neurodevelopment outcome is blinded.
Eligibility
Inclusion criteria
* Neonates of at least 32 weeks of gestation, infants and children up to 2 years of age admitted to The Children's Hospital for treatment of cyanotic or non-cyanotic heart disease requiring surgical intervention. * Admitting diagnosis of cyanotic or non-cyanotic heart disease
Exclusion criteria
* Neonates less than 32 weeks of gestational age, and children more than 2 years of age. * Any documented central nervous system malformations. * Any potential subject requiring unexpected postoperative Extracorporeal membrane oxygenation (ECMO) support
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Bayley III | Assessed once between age 18 to 48 months (approximately 2 hours to assess), up to 48 months from study start | Neurodevelopmental assessment scores are age dependent and based motor and behavioral abilities, often reported for normal or abnormal for age. Bayley Scales of Infant and Toddler Development, third edition, (Bayley III) is an instrument designed to measure the developmental functioning of infants and toddlers between the ages of 1 month and 42 months (age adjustments for prematurity are accommodated with the tool). It provides age specific composite scores for cognitive (91 items, score min 55 max 145), language (98 items, score min 47 max 153), and motor (138 items, score min 46 max 154) skills. For all scales, higher scores are better and lower scores indicate possible delay/deficit. |
| Electroencephalogram | EEG taken immediately prior to surgery, during surgery, during cardiovascular intensive care unit (CVICU) stay (up to 48 hours after surgery), and immediately prior to discharge (between 5 to 20 minutes to assess EEG at each time point) | Brain electrical activity: observation is for brain region specific abnormal or seizure activity. Number of participants with abnormal EEG are reported. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Lactate | 0-72 hours | blood levels:time and patient dependent variation, observed patient related trends over time |
| Choline | 0-72 hours | blood levels: time and patient dependent variation, observed patient related trends over time |
| Glutamate | 0-72 hours | blood levels:time and patient dependent variation, observed patient related trends over time |
| N-acetylaspartate (Naa) | 0-72 hours | blood levels:time and patient dependent variation, observed patient related trends over time |
Countries
United States
Participant flow
Pre-assignment details
Randomization data are available for only 89 of the 153 participants enrolled.
Participants by arm
| Arm | Count |
|---|---|
| Narcotic Based Anesthesia Participants receive fentanyl 5 mcg/kg/hr not to exceed 10 mcg/kg/hr (high dose). | 44 |
| Volatile Anesthesia Participants receive volatile anesthetic isoflurane (1.5-2.0%) as primary anesthetic; participants also receive rocuronium or pancuronium for muscle relaxation, and fentanyl at no greater than 2 mcg/kg/hr (low dose). | 45 |
| Total | 89 |
Baseline characteristics
| Characteristic | Narcotic Based Anesthesia | Volatile Anesthesia | Total |
|---|---|---|---|
| Age, Continuous | 8.1 months STANDARD_DEVIATION 8.5 | 6.2 months STANDARD_DEVIATION 8.5 | 7.1 months STANDARD_DEVIATION 8.5 |
| Race/Ethnicity, Customized Asian | 9 Participants | 8 Participants | 17 Participants |
| Race/Ethnicity, Customized Black or African American | 1 Participants | 2 Participants | 3 Participants |
| Race/Ethnicity, Customized Caucasian | 20 Participants | 18 Participants | 38 Participants |
| Race/Ethnicity, Customized Hispanic | 14 Participants | 15 Participants | 29 Participants |
| Race/Ethnicity, Customized Native Hawaiian or Other Pacific Highlander | 0 Participants | 2 Participants | 2 Participants |
| Region of Enrollment United States | 44 Participants | 45 Participants | 89 Participants |
| Sex: Female, Male Female | 18 Participants | 20 Participants | 38 Participants |
| Sex: Female, Male Male | 26 Participants | 25 Participants | 51 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 3 / 44 | 1 / 45 |
| other Total, other adverse events | 0 / 44 | 0 / 45 |
| serious Total, serious adverse events | 7 / 44 | 10 / 45 |
Outcome results
Bayley III
Neurodevelopmental assessment scores are age dependent and based motor and behavioral abilities, often reported for normal or abnormal for age. Bayley Scales of Infant and Toddler Development, third edition, (Bayley III) is an instrument designed to measure the developmental functioning of infants and toddlers between the ages of 1 month and 42 months (age adjustments for prematurity are accommodated with the tool). It provides age specific composite scores for cognitive (91 items, score min 55 max 145), language (98 items, score min 47 max 153), and motor (138 items, score min 46 max 154) skills. For all scales, higher scores are better and lower scores indicate possible delay/deficit.
Time frame: Assessed once between age 18 to 48 months (approximately 2 hours to assess), up to 48 months from study start
Population: Participants with a completed Bayley III assessment are included in the analysis.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Narcotic Based Anesthesia | Bayley III | Cognitive Standard Score | 91 score on a scale | Standard Deviation 10 |
| Narcotic Based Anesthesia | Bayley III | Language Standard Score | 88 score on a scale | Standard Deviation 11 |
| Narcotic Based Anesthesia | Bayley III | Motor Standard Score | 97 score on a scale | Standard Deviation 13 |
| Volatile Anesthesia | Bayley III | Motor Standard Score | 90 score on a scale | Standard Deviation 15 |
| Volatile Anesthesia | Bayley III | Cognitive Standard Score | 93 score on a scale | Standard Deviation 15 |
| Volatile Anesthesia | Bayley III | Language Standard Score | 90 score on a scale | Standard Deviation 18 |
Electroencephalogram
Brain electrical activity: observation is for brain region specific abnormal or seizure activity. Number of participants with abnormal EEG are reported.
Time frame: EEG taken immediately prior to surgery, during surgery, during cardiovascular intensive care unit (CVICU) stay (up to 48 hours after surgery), and immediately prior to discharge (between 5 to 20 minutes to assess EEG at each time point)
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Narcotic Based Anesthesia | Electroencephalogram | Abnormal preoperative EEG | 0 Participants |
| Narcotic Based Anesthesia | Electroencephalogram | Abnormal intraoperative EEG | 1 Participants |
| Narcotic Based Anesthesia | Electroencephalogram | Abnormal EEG in CVICU | 0 Participants |
| Narcotic Based Anesthesia | Electroencephalogram | Abnormal EEG predischarge | 0 Participants |
| Volatile Anesthesia | Electroencephalogram | Abnormal EEG predischarge | 0 Participants |
| Volatile Anesthesia | Electroencephalogram | Abnormal preoperative EEG | 0 Participants |
| Volatile Anesthesia | Electroencephalogram | Abnormal EEG in CVICU | 1 Participants |
| Volatile Anesthesia | Electroencephalogram | Abnormal intraoperative EEG | 1 Participants |
Choline
blood levels: time and patient dependent variation, observed patient related trends over time
Time frame: 0-72 hours
Population: Data were not collected for this outcome measure.
Glutamate
blood levels:time and patient dependent variation, observed patient related trends over time
Time frame: 0-72 hours
Population: Data were not collected for this outcome measure.
Lactate
blood levels:time and patient dependent variation, observed patient related trends over time
Time frame: 0-72 hours
Population: Data were not collected for this outcome measure.
N-acetylaspartate (Naa)
blood levels:time and patient dependent variation, observed patient related trends over time
Time frame: 0-72 hours
Population: Data were not collected for this outcome measure.